
HDFC AMC vs Nippon Life India AMC vs UTI AMC: Which Stock Should You Track
HDFC AMC PE 35.23, mkt cap Rs 1,03,849 crore. Nippon Life India AMC PE 45.35, mkt cap Rs 74,245 crore. UTI AMC PE 23.05, mkt cap Rs 11,813 crore.
Updated: 23 Sept 2026 • 10:46 am
Posted by:

Quick Answer
HDFC AMC vs Nippon Life India AMC vs UTI AMC is a side-by-side comparison of three companies from the Asset Management (AMC) space. On this comparison, HDFC AMC carries a market capitalisation of about Rs 1,03,849 crore against Rs 74,245 crore for Nippon Life India AMC and Rs 11,813 crore for UTI AMC, with return on equity of 30.97%, 32.83% and 10.67% respectively. Each company's numbers are presented here without a declared better pick, since the right stock depends on an investor's own criteria.
HDFC AMC vs Nippon Life India AMC vs UTI AMC starts with the core numbers most investors compare within the Asset Management (AMC) segment: market capitalisation, valuation multiples, profitability and dividend yield. Figures below are sourced as of September 2026 and will shift with daily price moves.
All three names sit in the Asset Management (AMC) bucket, which makes them a natural set to place side by side rather than a random trio of unrelated businesses.
Click Here – Get Free Investment Predictions
HDFC AMC, Nippon Life India AMC and UTI AMC: Company Overview
HDFC AMC is a listed Indian company in the Asset Management (AMC) space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.
Nippon Life India AMC is a listed Indian company in the Asset Management (AMC) space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.
UTI AMC is a listed Indian company in the Asset Management (AMC) space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.
HDFC AMC vs Nippon Life India AMC vs UTI AMC: Valuation and Profitability Snapshot
| Metric | HDFC AMC | Nippon Life India AMC | UTI AMC |
|---|---|---|---|
| Market Cap (approx.) | Rs 1,03,849 crore | Rs 74,245 crore | Rs 11,813 crore |
| PE Ratio (TTM) | 35.23 | 45.35 | 23.05 |
| PB Ratio | 11.25 | 15.93 | 2.62 |
| Return on Equity (ROE) | 30.97% | 32.83% | 10.67% |
| EPS (TTM, Rs) | 68.70 | 25.58 | 39.87 |
| Dividend Yield | 2.23% | 1.85% | 4.35% |
| Debt to Equity | 0.00 | 0.02 | 0.03 |
| Book Value per Share (Rs) | 215.09 | 72.82 | 350.44 |
Check the Univest Screener for Live Data
On valuation, HDFC AMC trades at a PE of 35.23 and a PB of 11.25, Nippon Life India AMC at a PE of 45.35 and a PB of 15.93, while UTI AMC trades at a PE of 23.05 and a PB of 2.62. On return on equity, the three post 30.97%, 32.83% and 10.67% respectively, and on dividend yield they stand at 2.23%, 1.85% and 4.35%.
HDFC AMC vs Nippon Life India AMC vs UTI AMC: Latest Quarterly Results
| Company | Latest Quarter Revenue | Latest Quarter Net Profit | YoY Change (Revenue) | QoQ Change (Revenue) |
|---|---|---|---|---|
| HDFC AMC | Rs 1,362.56 crore | Rs 837.13 crore | +13.4% | +28.2% |
| Nippon Life India AMC | Rs 937.08 crore | Rs 503.09 crore | +24.5% | +32.9% |
| UTI AMC | Rs 585.23 crore | Rs 293.86 crore | +6.7% | +45.6% |
Quarterly figures above are the most recent reported quarter for each company (Q1 FY28, quarter ended June 2026), compared with the year-ago and preceding quarter.
Download the Univest iOS App or Univest Android App to track HDFC AMC, Nippon Life India AMC and UTI AMC live prices.
What Should Investors Look at Beyond These Numbers?
Beyond the metrics above, investors comparing these three asset management (amc) names should track quarter-on-quarter revenue and margin trends, management commentary on demand and cost drivers, and any sector-specific regulatory developments, since a single-quarter snapshot can shift quickly.
Conclusion
HDFC AMC vs Nippon Life India AMC vs UTI AMC highlights how differently three companies in the same asset management (amc) segment can score across valuation, profitability and dividend metrics, even when operating in a similar space. This comparison does not declare a winner; investors should weigh these figures against their own research and risk appetite. Please read the disclaimer below before making any investment decision.
Disclaimer: Data and figures in this article are sourced from publicly available information as of September 2026 and may not reflect real-time prices. Please verify all data independently before making any investment decision. This comparison does not recommend or endorse any single stock over another; investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on HDFC AMC vs Nippon Life India AMC vs UTI AMC
What is the market cap difference between HDFC AMC, Nippon Life India AMC and UTI AMC?
Ans. As of September 2026, HDFC AMC has a market cap of approximately Rs 1,03,849 crore, Nippon Life India AMC is at approximately Rs 74,245 crore, and UTI AMC is at approximately Rs 11,813 crore.
Which of the three has the highest PE ratio?
Ans. Among HDFC AMC, Nippon Life India AMC and UTI AMC, the PE ratios stand at 35.23, 45.35 and 23.05 respectively as of September 2026.
Which of the three has the highest ROE?
Ans. HDFC AMC, Nippon Life India AMC and UTI AMC post ROE of 30.97%, 32.83% and 10.67% respectively as of September 2026.
Which of these three stocks pays the highest dividend yield?
Ans. HDFC AMC, Nippon Life India AMC and UTI AMC carry dividend yields of 2.23%, 1.85% and 4.35% respectively.
What is the debt to equity ratio for HDFC AMC, Nippon Life India AMC and UTI AMC?
Ans. HDFC AMC carries a debt to equity of 0.00, Nippon Life India AMC of 0.02, and UTI AMC of 0.03.
Which of the three trades at the highest price to book value?
Ans. HDFC AMC, Nippon Life India AMC and UTI AMC trade at price to book ratios of 11.25, 15.93 and 2.62 respectively.
Is one of HDFC AMC, Nippon Life India AMC or UTI AMC better than the others?
Ans. This comparison does not declare one stock better than another; each company scores differently across valuation, profitability and dividend metrics, and the right fit depends on an individual investor's own criteria and research.
Recent Articles

Caplin Point Laboratories: 7 Stock Signals Investors Are Watching Right Now
23 September 2026

Zydus Wellness: 7 Stock Signals Investors Are Watching Right Now
23 September 2026

Alembic Pharmaceuticals: 7 Stock Signals Investors Are Watching Right Now
23 September 2026

Dr. Lal PathLabs: 7 Stock Signals Investors Are Watching Right Now
23 September 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Caplin Point Laboratories: 7 Stock Signals Investors Are Watching Right Now
Zydus Wellness: 7 Stock Signals Investors Are Watching Right Now
Alembic Pharmaceuticals: 7 Stock Signals Investors Are Watching Right Now
Dr. Lal PathLabs: 7 Stock Signals Investors Are Watching Right Now
JB Chemicals and Pharmaceuticals: 7 Stock Signals Investors Are Watching Right Now

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





